Concepedia

B. Bennett

BB

5

Publications

237

Citations

5

H-Index

1986

Active since

Affiliations

UCB Pharma (Belgium)(Current)

UCB Pharma (United States)

Università Cattolica del Sacro Cuore

Medical University of Vienna

Poznan University of Medical Sciences

B. Bennett is an author at UCB Pharma (Belgium) specializing in medicine, mood disorders, and depression.

Top concepts

Publications per year

1986–2014

5

Publications

5

Certolizumab pegol in rheumatoid arthritis patients with low to moderate activity: the CERTAIN double-blind, randomised, placebo-controlled trial

Josef S Smolen, Paul Emery, Gianfranco Ferraccioli et al. · Annals of the Rheumatic Diseases · 2014 · 108 citations · Full text

Continuation and maintenance treatment of major depression with the monoamine oxidase inhibitor phenelzine: a double-blind placebo-controlled discontinuation study.

Donald S. Robinson, Sidney Lerfald, B. Bennett et al. · PubMed · 1991 · 75 citations

, , +19

Haemoglobin concentration and linear cardiac output, peripheral resistance, and oxygen transport.

Malini Daniel, B. Bennett, Audrey A. Dawson et al. · BMJ · 1986 · 24 citations · Full text

, , +17

FRI0150 Maintenance of remission in rheumatoid arthritis patients with low-moderate disease activity following withdrawal of certolizumab PEGOL treatment: Week 52 results from the certain study

Josef S Smolen, Paul Emery, Gianfranco Ferraccioli et al. · Annals of the Rheumatic Diseases · 2012 · 16 citations

Two Dosing Regimens of Certolizumab Pegol in Patients With Active Rheumatoid Arthritis

Daniel E. Furst, Saeed Ahmed Shaikh, Maria Greenwald et al. · Arthritis Care & Research · 2014 · 14 citations · Full text

Rows per page

1–5 of 5